Pfizer nears $68 billion deal to buy Wyeth: sources

PHILADELPHIA/AMSTERDAM (Reuters) – Pfizer Inc, the No.1 drugmaker, was close to a billion purchase of U.S. rival Wyeth in a move to diversify its revenue base, sources familiar with the situation said.

Comments are closed.